Virios Therapeutics, Inc. (VIRI) Prices 3M Share IPO at $10/Sh

Virios Therapeutics, Inc. (NASDAQ: VIRI), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $30 million, before deducting underwriting discounts, commissions and offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 450,000 shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments.

The shares are expected to begin trading on the Nasdaq Capital Market on December 17, 2020 under the ticker symbol “VIRI.” The offering is expected to close on December 21, 2020, subject to satisfaction of customary closing conditions.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.

You May Also Be Interested In

• Rubrik, Inc. (RBRK) IPO Opens at $38.60, Priced at $32
• Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
• Rubrik (RBRK) Prices 23M Share IPO at $32/sh, Above Indicated $28-$31/sh Range - Reuters